1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South America Virology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South America Virology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South America Virology Market Regional Analysis
6.2 South America Virology Market Revenue 2019-2028 (US$ Million)
6.3 South America Virology Market Forecast Analysis
7. South America Virology Market Analysis – by Type
7.1 Diagnostic Test
- 7.1.1 Overview
- 7.1.2 Diagnostic Test: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Viral Infection Controlling Techniques
- 7.2.1 Overview
- 7.2.2 Viral Infection Controlling Techniques: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Antiviral Therapeutics
- 7.3.1 Overview
- 7.3.2 Antiviral Therapeutics: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Interferons
- 7.4.1 Overview
- 7.4.2 Interferons: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. South America Virology Market Analysis – by Application
8.1 Skin and Soft Tissue Infections
- 8.1.1 Overview
- 8.1.2 Skin and Soft Tissue Infections: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Respiratory Tract Infections
- 8.2.1 Overview
- 8.2.2 Respiratory Tract Infections: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 GI Tract Infections
- 8.3.1 Overview
- 8.3.2 GI Tract Infections: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Sexually Transmitted Diseases
- 8.4.1 Overview
- 8.4.2 Sexually Transmitted Diseases: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Urinary Tract Infection
- 8.5.1 Overview
- 8.5.2 Urinary Tract Infection: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. South America Virology Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical and Biotechnological Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biotechnological Companies: South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Research and Academic Institutes
- 9.4.1 Overview
- 9.4.2 Research and Academic Institutes : South America Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. South America Virology Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South America Virology Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 South America Virology Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South America Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 Brazil: South America Virology Market Breakdown, by Type
- 10.2.1.1.2 Brazil: South America Virology Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South America Virology Market Breakdown, by End User
- 10.2.1.2 Argentina:
South America Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Argentina: South America Virology Market Breakdown, by Type
- 10.2.1.2.2 Argentina: South America Virology Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South America Virology Market Breakdown, by End User
- 10.2.1.3 Rest of South and Central America :
South America Virology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : South America Virology Market Breakdown, by Type
- 10.2.1.3.2 Rest of South and Central America : South America Virology Market Breakdown, by Application
- 10.2.1.3.3 Rest of South and Central America : South America Virology Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AbbVie Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Gilead Sciences, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GlaxoSmithKline Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 QIAGEN
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations